Long-Term Safety and Efficacy of Tetrabenazine in the Treatment of Chorea Associated with Huntington's Disease

被引：0
|
作者：
Shen, Vivienne [1 ]
Clarence-Smith, Kathleen [2 ]
Hunter, Christine [3 ]
Jankovic, Joseph [3 ]
机构：
[1] Lundbeck Inc, Deerfield, IL USA
[2] KM Pharmaceut Consulting LLC, Washington, DC USA
[3] Baylor Coll Med, Houston, TX 77030 USA
来源：
NEUROLOGY | 2012年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P06034
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Tetrabenazine in the management of motor symptoms of Huntington's disease: Long-term effect in a large series
    Fasano, A.
    Cadeddu, F.
    Guidubaldi, A.
    Bentivoglio, A.
    MOVEMENT DISORDERS, 2006, 21 : S361 - S361
  • [32] Donepezil in the treatment of Alzheimer's disease - Long-term efficacy and safety
    Rocca, P
    Cocuzza, E
    Marchiaro, L
    Bogetto, F
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (02): : 369 - 373
  • [33] Long-Term Efficacy and Safety of Infliximab in the Treatment of Behcet's Disease
    Capella, Maria Jose
    Foster, C. Stephen
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2012, 20 (03) : 198 - 202
  • [34] Long-term safety and efficacy of selegiline in the treatment of Parkinson's disease
    Maki-Ikola, O
    Heinonen, E
    Lammintausta, R
    NEUROCHEMISTRY: CELLULAR, MOLECULAR, AND CLINICAL ASPECTS, 1997, : 331 - 337
  • [35] EFFICACY, SAFETY, AND TOLERABILITY OF AFQ056 FOR THE TREATMENT OF CHOREA IN PATIENTS WITH HUNTINGTON'S DISEASE
    Reilmann, R.
    Rouzade-Dominguez, M.
    Saft, C.
    Suessmuth, S. D.
    Priller, J.
    Rosser, A.
    Rickards, H.
    Schoels, L.
    Pezous, N.
    Gasparini, F.
    Landwehrmeyer, G. B.
    Johns, D.
    Gomez-Mancilla, B.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 : A102 - A103
  • [36] Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease
    Frank, Samuel
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 657 - 665
  • [37] Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease
    Frank, Samuel
    Anderson, Karen E.
    Fernandez, Hubert H.
    Hauser, Robert A.
    Claassen, Daniel O.
    Stamler, David
    Factor, Stewart A.
    Jimenez-Shahed, Joohi
    Barkay, Hadas
    Wilhelm, Amanda
    Alexander, Jessica K.
    Chaijale, Nayla
    Barash, Steve
    Savola, Juha-Matti
    Gordon, Mark Forrest
    Chen, Maria
    NEUROLOGY AND THERAPY, 2024, 13 (03) : 655 - 675
  • [38] Demographic and Clinical Characteristics and Tetrabenazine (TBZ) Persistence in Patients with Huntington's disease (HD)-Associated Chorea
    Sung, V.
    Iyer, R.
    Gandhi, S.
    Abler, V.
    Davis, B.
    Irwin, D.
    Anderson, K.
    MOVEMENT DISORDERS, 2017, 32
  • [39] Long-term efficacy and safety of golimumab in the treatment of multirefractory Behcet's disease
    Vitale, Antonio
    Emmi, Giacomo
    Lopalco, Giuseppe
    Fabiani, Claudia
    Gentileschi, Stefano
    Silvestri, Elena
    Gerardo, Di Scala
    Iannone, Florenzo
    Frediani, Bruno
    Galeazzi, Mauro
    Lapadula, Giovanni
    Rigante, Donato
    Cantarini, Luca
    CLINICAL RHEUMATOLOGY, 2017, 36 (09) : 2063 - 2069
  • [40] Tolcapone in stable Parkinson's disease: Efficacy and safety of long-term treatment
    Waters, CH
    Kurth, M
    Bailey, P
    Shulman, LM
    LeWitt, P
    Dorflinger, E
    Deptula, D
    Pedder, S
    NEUROLOGY, 1997, 49 (03) : 665 - 671
12345